Breaking News Instant updates and real-time market news.

ALDR

Alder Biopharmaceuticals

$19.35

0.2 (1.04%)

16:23
08/07/18
08/07
16:23
08/07/18
16:23

Alder Biopharmaceuticals reports Q2 EPS ($1.04), consensus ($1.05)

"During the second quarter, the new data we presented from our Phase 3 clinical trials in episodic and chronic migraine further highlighted eptinezumab's encouraging clinical profile for migraine prevention, including increased efficacy following additional quarterly infusions. Alder is focused on changing the treatment paradigm for the millions of patients living with the disabling effects of migraine and we remain on track to submit a high-quality BLA to the U.S. Food and Drug Administration in the first quarter of 2019," said CEO Robert Azelby. As of June 30, 2018, Alder had $536.1M in cash, cash equivalents, investments and restricted cash compared to $587.0M as of March 31, 2018. Alder believes its available cash, cash equivalents, short-term investments and restricted cash will be sufficient to meet the company's projected operating requirements into 2020.

  • 07

    Aug

  • 08

    Aug

ALDR Alder Biopharmaceuticals
$19.35

0.2 (1.04%)

06/27/18
NEED
06/27/18
INITIATION
Target $28
NEED
Buy
Alder Biopharmaceuticals assumed with a Buy at Needham
Needham analyst Serge Belanger assumed Alder Biopharmaceuticals with a Buy rating and a price target of $28, saying the company is positioned as a "rare pure-play migraine story". Belanger cites the positive pivotal phase 3 trial data for its Eptinezumab drug where it met all the endpoints and demonstrated an efficacy profile relative to competitive treatments. The analyst believes that Eptinezumab will appeal to "most severe of migraine patients where it will generate blockbuster-level sales" of over $1B.
08/06/18
PIPR
08/06/18
INITIATION
Target $28
PIPR
Overweight
Alder Biopharmaceuticals initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Danielle Brill started Alder Biopharmaceuticals with an Overweight rating and $28 price target. Alder is undervalued despite having a "late-stage, de-risked, and differentiated" asset that addresses the large, under-served migraine population, Brill tells investors in a research note. The analyst finds the stock "very attractive at current levels."
08/06/18
08/06/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Global Blood Therapeutics (GBT) initiated with an Overweight at Piper Jaffray. 2. Welltower (WELL) reinstated with a Neutral at Goldman Sachs. 3. Sage Therapeutics (SAGE) initiated with an Overweight at Piper Jaffray. 4. SoftBank (SFTBY) initiated with a Buy at UBS. 5. Alder Biopharmaceuticals (ALDR) initiated with an Overweight at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/07/18
STFL
08/07/18
INITIATION
Target $30
STFL
Buy
Alder Biopharmaceuticals initiated with a Buy at Stifel
Stifel analyst Paul Matteis initiated coverage of Alder BioPharmaceuticals with a Buy rating and $30 price target, calling it an attractive, differentiated "pure play" within the migraine antiCGRP prevention market. While Matteis acknowledges it "won't be easy" for Alder to compete with Amgen (AMGN), Novartis (NVS), Eli Lilly (LLY) and Teva (TEVA), he believes the unique profile of eptinezumab remains underappreciated and may allow it to capture meaningful, above consensus share of a large, emerging drug category.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,026.00

7 (0.69%)

, GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

18:19
11/20/18
11/20
18:19
11/20/18
18:19
Periodicals
Google expands Moffett Park presence again, SVBJ says »

Google is once again…

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Mar

SE

Sea Limited

$12.18

-0.52 (-4.09%)

18:04
11/20/18
11/20
18:04
11/20/18
18:04
Earnings
Sea Limited reports Q3 net loss ($237.6M) vs. ($127.1M) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$13.61

0.575 (4.41%)

18:03
11/20/18
11/20
18:03
11/20/18
18:03
Earnings
Bilibili reports Q3 revenue $157.1M, consensus $146.72M »

Reports Q3 adjusted net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LTM

Latam Airlines

$9.24

-0.4 (-4.15%)

18:01
11/20/18
11/20
18:01
11/20/18
18:01
Hot Stocks
Breaking Hot Stocks news story on Latam Airlines »

LATAM Airlines reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CE

Celanese

$100.26

-1.53 (-1.50%)

18:01
11/20/18
11/20
18:01
11/20/18
18:01
Hot Stocks
Celanese increases Fortron polyphenylene sulphide price by 85c per kg »

The price increases will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$317.77

-3.09 (-0.96%)

, TSLA

Tesla

$347.60

-5.88 (-1.66%)

17:55
11/20/18
11/20
17:55
11/20/18
17:55
Periodicals
NASA to investigate workplace culture at Boeing, SpaceX, Reuters says »

NASA said that it plans…

BA

Boeing

$317.77

-3.09 (-0.96%)

TSLA

Tesla

$347.60

-5.88 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 13

    Dec

PLWTY

Panalpina World Transport

$0.00

(0.00%)

17:52
11/20/18
11/20
17:52
11/20/18
17:52
Upgrade
Panalpina World Transport rating change  »

Panalpina World Transport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

17:52
11/20/18
11/20
17:52
11/20/18
17:52
Hot Stocks
British Columbia sets path for 100% zero-emission vehicle sales by 2040 »

In a move aimed at…

VLKAY

Volkswagen

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$117.29

0.2 (0.17%)

F

Ford

$9.06

-0.19 (-2.05%)

HMC

Honda

$27.60

-0.46 (-1.64%)

GM

General Motors

$35.09

-0.58 (-1.63%)

FCAU

Fiat Chrysler

$15.83

-0.585 (-3.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

SPY

SPDR S&P 500 ETF Trust

$264.12

-5.16 (-1.92%)

, SPX

S&P 500

$0.00

(0.00%)

17:45
11/20/18
11/20
17:45
11/20/18
17:45
General news
U.S says China has not changed its 'unfair' trade practices »

The Office of the United…

SPY

SPDR S&P 500 ETF Trust

$264.12

-5.16 (-1.92%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBA

Ritchie Bros.

$34.27

-0.24 (-0.70%)

17:42
11/20/18
11/20
17:42
11/20/18
17:42
Recommendations
Ritchie Bros. analyst commentary  »

Ritchie Bros exhibiting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:39
11/20/18
11/20
17:39
11/20/18
17:39
Earnings
Breaking Earnings news story on Foot Locker »

Foot Locker sees Q4 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FE

FirstEnergy

$37.96

-0.58 (-1.50%)

17:39
11/20/18
11/20
17:39
11/20/18
17:39
Periodicals
FirstEnergy in pact to sell West Lorain facility to Starwood Energy, WSJ says »

FirstEnergy Generation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIZZ

National Beverage

$90.53

-3.14 (-3.35%)

17:39
11/20/18
11/20
17:39
11/20/18
17:39
Hot Stocks
National Beverage announces special cash dividend of $2.90 per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSK

Oshkosh

$65.31

-0.81 (-1.23%)

17:30
11/20/18
11/20
17:30
11/20/18
17:30
Syndicate
Breaking Syndicate news story on Oshkosh »

Oshkosh files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 05

    Dec

MDU

MDU Resources

$26.10

-0.49 (-1.84%)

17:27
11/20/18
11/20
17:27
11/20/18
17:27
Hot Stocks
MDU Resources sees 2019-2023 CapEx $2.6B »

"We have identified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDU

MDU Resources

$26.10

-0.49 (-1.84%)

17:26
11/20/18
11/20
17:26
11/20/18
17:26
Earnings
MDU Resources narrows FY18 EPS view to $1.30-$1.45 from $1.25-$1.45 

FY18 consensus $1.39.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:22
11/20/18
11/20
17:22
11/20/18
17:22
Earnings
Foot Locker backs FY18 EPS growth view in double digits, consensus $4.48 »

Backs FY18 SSS growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:19
11/20/18
11/20
17:19
11/20/18
17:19
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker sees Q4 SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.10

-2.69 (-5.51%)

17:17
11/20/18
11/20
17:17
11/20/18
17:17
Hot Stocks
Foot Locker says women's business was the strongest in footwear »

Says pleased by Foot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CPRT

Copart

$47.30

-1.255 (-2.58%)

17:16
11/20/18
11/20
17:16
11/20/18
17:16
Earnings
Copart reports Q1 fully diluted EPS 47c, consensus 47c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

17:16
11/20/18
11/20
17:16
11/20/18
17:16
Hot Stocks
DexCom and Verily amend license agreementAlphabet Class A »

DexCom (DXCM) and Verily,…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

VNET

21Vianet

$11.20

-0.1 (-0.88%)

17:12
11/20/18
11/20
17:12
11/20/18
17:12
Earnings
21Vianet reports Q3 adjusted EBITDA up 81.6% to RMB 45.2M »

Reports Q3 revenue RMB…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

DXCM

DexCom

$119.89

-1.34 (-1.11%)

17:05
11/20/18
11/20
17:05
11/20/18
17:05
Syndicate
Breaking Syndicate news story on DexCom »

DexCom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

RDC

Rowan Companies

$14.32

-0.74 (-4.91%)

, ESV

Ensco

$6.19

-0.36 (-5.50%)

17:02
11/20/18
11/20
17:02
11/20/18
17:02
Hot Stocks
Rowan Companies and Ensco granted early termination of waiting period »

Rowan Companies (RDC) and…

RDC

Rowan Companies

$14.32

-0.74 (-4.91%)

ESV

Ensco

$6.19

-0.36 (-5.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMBK

SmartFinancial

$20.14

-0.56 (-2.71%)

17:00
11/20/18
11/20
17:00
11/20/18
17:00
Hot Stocks
SmartFinancial authorizes $10M stock repurchase plan »

SmartFinancial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.